Structure Therapeutics Inc. Sponsored ADR GPCR

35.93 (0.09) (0.25%) as of 25 Sep
Market cap
$2.6B
P/E
0.0×
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Current Ratio
20.75 26.16 24.81 14.15

+8 more quarters

Net Debt/EBITDA
11.05 15.84 (38.49) 10.41
Debt/Assets
0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00
Asset Turnover
0.00 0.00 0.00 0.00
Operating CF/Net income
1.13 (0.20) (1.95) 0.78
Capex/Depreciation
(0.01) 0.44 (0.11) 0.54
Interest Coverage
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00%
Free Cash Flow per Share
(1.65) 0.19 (1.11) (0.90)
Cash per Share
18.48 20.13 24.43 13.66
Shareholders Equity per Share
18.64 19.98 25.61 13.17
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
18.64 19.98 25.61 13.17
Free Cash Flow
(120.07) 14.05 (65.91) (52.57)
Working Capital
1,305.92 1,433.61 1,507.02 756.50
Capital Expenditures
0.04 (1.18) (1.50) (1.57)
Net Current Asset Value
1,301.02 1,429.57 1,502.76 751.88
Other line items
Quick Ratio
20.31 25.60 24.43 13.89
Revenue per Share
0.00 0.00 0.00 0.00
Operating CF per Share
(1.65) 0.21 (1.09) (0.87)
Capex per Share
0.00 (0.02) (0.03) (0.03)
Average Payables
10.06 8.27 10.94 13.12
Average Assets
1,120.93 1,187.34 1,243.62 882.69
Average Common Equity
1,063.24 1,135.87 1,190.61 833.41
Capex to Sales
0.00 0.00 0.00 0.00
Net Profit Margin
0.00% 0.00% 0.00% 0.00%

Fold the line items

Columns are period end dates